• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXHS2400102 替尔泊肽注射液 tirzepatide Injection Chemical Drugs(5.1) Import Drug Application 2024-11-22 Eli Lilly & Company;Eli Lilly Nederland BV;Lilly Suzhou Pharmaceutical Co Ltd view
JXHS2300080 替尔泊肽注射液 tirzepatide Injection Chemical Drugs(2.4) Import Drug Application 2023-08-21 Eli Lilly & Company;Lilly Suzhou Pharmaceutical Co Ltd view
JXHS2500064 替尔泊肽注射液 tirzepatide Injection Chemical Drugs(5.1) Import Drug Application 2025-06-07 Eli Lilly & Company;Eli Lilly Nederland BV;Lilly Suzhou Pharmaceutical Co Ltd view
JYHB2400489 替尔泊肽注射液 tirzepatide Injection Chemical Drugs(5.1) Supplementary Application 2024-09-11 Eli Lilly & Company;Eli Lilly Nederland BV view
JYHB2400540 替尔泊肽注射液 tirzepatide Injection Chemical Drugs(5.1) Supplementary Application 2024-10-13 Eli Lilly Nederland BV;Eli Lilly Italia SpA view
JXHS2200078 替尔泊肽注射液 tirzepatide Injection Chemical Drugs(5.1) Import Drug Application 2022-09-07 Eli Lilly & Company;Lilly Suzhou Pharmaceutical Co Ltd view
JXHS2400108 替尔泊肽注射液 tirzepatide Injection Chemical Drugs(2.4) Import Drug Application 2024-12-14 Eli Lilly & Company;Eli Lilly Nederland BV;Lilly Suzhou Pharmaceutical Co Ltd view
JYHB2400411 替尔泊肽注射液 tirzepatide Injection Chemical Drugs(5.1) Supplementary Application 2024-08-01 Eli Lilly & Company view
JXHS2400065 替尔泊肽注射液 tirzepatide Injection Chemical Drugs(2.4) Import Drug Application 2024-09-15 Eli Lilly & Company;Lilly Suzhou Pharmaceutical Co Ltd view
JXHS2400109 替尔泊肽注射液 tirzepatide Injection Chemical Drugs(2.4) Import Drug Application 2024-12-14 Eli Lilly & Company;Eli Lilly Nederland BV;Lilly Suzhou Pharmaceutical Co Ltd view
JYHB2400413 替尔泊肽注射液 tirzepatide Injection Chemical Drugs(5.1) Supplementary Application 2024-08-01 Eli Lilly & Company view
JXHS2400068 替尔泊肽注射液 tirzepatide Injection Chemical Drugs(2.4) Import Drug Application 2024-09-15 Eli Lilly & Company;Lilly Suzhou Pharmaceutical Co Ltd view
JXHS2400099 替尔泊肽注射液 tirzepatide Injection Chemical Drugs(5.1) Import Drug Application 2024-11-22 Eli Lilly & Company;Eli Lilly Nederland BV;Lilly Suzhou Pharmaceutical Co Ltd view
JXHS2300079 替尔泊肽注射液 tirzepatide Injection Chemical Drugs(2.4) Import Drug Application 2023-08-21 Eli Lilly & Company;Lilly Suzhou Pharmaceutical Co Ltd view
JXHS2500063 替尔泊肽注射液 tirzepatide Injection Chemical Drugs(5.1) Import Drug Application 2025-06-07 Eli Lilly & Company;Eli Lilly Nederland BV;Lilly Suzhou Pharmaceutical Co Ltd view
JYHB2400488 替尔泊肽注射液 tirzepatide Injection Chemical Drugs(5.1) Supplementary Application 2024-09-11 Eli Lilly & Company;Eli Lilly Nederland BV view
JYHB2400542 替尔泊肽注射液 tirzepatide Injection Chemical Drugs(5.1) Supplementary Application 2024-10-13 Eli Lilly Nederland BV;Eli Lilly Italia SpA view
JXHS2200076 替尔泊肽注射液 tirzepatide Injection Chemical Drugs(5.1) Import Drug Application 2022-09-07 Eli Lilly & Company;Lilly Suzhou Pharmaceutical Co Ltd view
JXHS2400066 替尔泊肽注射液 tirzepatide Injection Chemical Drugs(2.4) Import Drug Application 2024-09-15 Eli Lilly & Company;Lilly Suzhou Pharmaceutical Co Ltd view
JXHS2400101 替尔泊肽注射液 tirzepatide Injection Chemical Drugs(5.1) Import Drug Application 2024-11-22 Eli Lilly & Company;Eli Lilly Nederland BV;Lilly Suzhou Pharmaceutical Co Ltd view